Pancreatitis: Zepbound may cause pancreatitis as a side effect
Providing mechanistic insights into the relative contribution of each receptor pathway to overall metabolic outcomes
When considering the use of Tirzepatide for weight loss, its important to take into account the unique considerations that apply to special populations
The emergence of oral GLP-1s, once-monthly injectables, dual- and triple-receptor targets and combination therapies has enhanced patient convenience, improved adherence and broadened clinical utility, bringing healthcare practitioners more options for individualized treatment
1.5-3.0 g/day for one year) in individuals with diabetic peripheral neuropathy (3, 88)
Retrieved from Dailey, R., Romo, L., Myer, S., et al